Studies have shown that tumor burden including tumor size and tumor number, biomarkers including AFP and NLR, post-treatment extent of disease (POST-TEXT) stages, tumor differentiation, vascular invasion, and chemotherapy could predict the prognosis of liver cancer patients undergoing LT (25, 26). This evidence concerns the gene AFP and neoplasm.